Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2013 1
2014 2
2015 1
2017 2
2018 1
2019 1
2020 4
2021 1
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trial.
Akbari N, Ostadrahimi A, Tutunchi H, Pourmoradian S, Farrin N, Najafipour F, Soleimanzadeh H, Kafil B, Mobasseri M. Akbari N, et al. Among authors: farrin n. J Trace Elem Med Biol. 2022 May;71:126945. doi: 10.1016/j.jtemb.2022.126945. Epub 2022 Feb 12. J Trace Elem Med Biol. 2022. PMID: 35183882 Free PMC article. Clinical Trial.
Expression of NF-κB, IL-6, and IL-10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD-Combined effects of oleoylethanolamide supplementation and calorie restriction: A triple-blind randomized controlled clinical trial.
Tutunchi H, Ostadrahimi A, Saghafi-Asl M, Roshanravan N, Shakeri-Bavil A, Asghari-Jafarabadi M, Farrin N, Mobasseri M. Tutunchi H, et al. Among authors: farrin n. J Cell Physiol. 2021 Jan;236(1):417-426. doi: 10.1002/jcp.29870. Epub 2020 Jun 22. J Cell Physiol. 2021. PMID: 32572955 Clinical Trial.
Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes.
Tutunchi H, Ostadrahimi A, Saghafi-Asl M, Hosseinzadeh-Attar MJ, Shakeri A, Asghari-Jafarabadi M, Roshanravan N, Farrin N, Naemi M, Hasankhani M. Tutunchi H, et al. Among authors: farrin n. Pharmacol Res. 2020 Jun;156:104770. doi: 10.1016/j.phrs.2020.104770. Epub 2020 Mar 23. Pharmacol Res. 2020. PMID: 32217148 Clinical Trial.
16 results